Nisha Desai, MD
Dermatology · Portland, ORNPI 1265605984
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Eli Lilly at 53.3% of the total. Reporting peaked in 2022 at $5,678 and has fallen 96.6% since, to $192 in 2025.
Across 128 payments — averaging $78.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$5K
- Pfizer$3K
- AbbVie$631
- Johnson & Johnson$271
- Novartis$245
- Janssen Scientific Affairs, LLC$148
- plus $504 from 12 others
Across 91 payments — averaging $14,110 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$641K
- Sun Pharmaceutical Industries Inc.$383K
- Pfizer$162K
- Arcutis Biotherapeutics, Inc.$70K
- Eli Lilly$19K
- Amgen$10K
What the payments were for
- Consulting fees$4,90049%
- Travel & lodging$2,73027%
- Food & beverage$2,15922%
- Education$1972%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 11 | $5,318 |
| Pfizer | 31 | $2,868 |
| AbbVie(2 entities) | 34 | $631 |
| Johnson & Johnson | 5 | $271 |
| Novartis | 21 | $245 |
| Janssen Scientific Affairs, LLC | 1 | $148 |
| Sanofi | 6 | $148 |
| Lilly USA, LLC | 7 | $113 |
| E.r. Squibb & Sons, L.L.C. | 3 | $66 |
| Dermira, Inc. | 1 | $34 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Almirall LLC | 1 | $22 |
| Dermavant Sciences, Inc. | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| UCB, Inc. | 1 | $16 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,986 in reported general payments places this provider in the 85th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 470 | $6,504 |
| Hydroxychloroquine Sulfate | 84 | $3,657 |
| Hydrocortisone Butyrate | 17 | $2,506 |
| Doxycycline Monohydrate | 74 | $2,494 |
| Betamethasone Valerate | 58 | $2,265 |
| Doxycycline Hyclate | 42 | $2,032 |
| Betamethasone Dipropionate | 63 | $1,960 |
| Clobetasol Propionate | 59 | $1,801 |
| Tacrolimus | 20 | $1,518 |
| Ketoconazole | 65 | $1,104 |
| Finasteride | 134 | $1,023 |
| Mometasone Furoate | 37 | $820 |
| Triamcinolone Acetonide | 50 | $663 |
| Minocycline Hcl | 20 | $572 |
| Spironolactone | 24 | $515 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Portland
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
- Kathryn SchwarzenbergerPortland$34K
- Jon HanifinPortland$25K
- Phoebe RichPortland$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.